Potential application of zerumbone in the prevention and therapy of chronic human diseases

Abstract

© 2018 Elsevier Ltd Several active compounds from ‘Mother Nature’ have been found to be tailor-made therapeutics for the better management of numerous chronic ailments, with fewer adverse side effects. Zerumbone is one such molecule isolated from the rhizomes of Zingiber zerumbet (L.) Smith, a Zingiberaceae plant with significant medicinal values that has been used traditionally for treating stomach ache, ulcers, diabetes, leprosy, asthma, and skin diseases. Zerumbone has been found to be the most important active compound of Z. zerumbet, contributing to its anti-inflammatory, anti-microbial, anti-hypersensitivity, chemopreventive and chemotherapeutic activities. It has been established as a multi-targeted agent with potential to treat chronic diseases such as osteoarthritis, obesity, diabetes, diabetic nephropathy, diabetic retinopathy, chronic gastritis, neuropathic pain, atherosclerosis, inflammation and cancer through modulation of various cellular signaling cascades and antigen presentation pathways. Therefore, the present study focuses on zerumbone, its sources and biological activities against various chronic diseases by summarizing the literature available.